Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18968,132,1.20 [0.89-1.63],0.2338340466185225
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19786,150,0.81 [0.57-1.15],0.2427379958907733
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19574,1131,0.98 [0.87-1.11],0.7886245530453553
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,19800,296,1.06 [0.85-1.32],0.6039705447413168
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19201,2805,1.01 [0.93-1.08],0.8758664730221559
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19203,2826,1.04 [0.97-1.12],0.2261984259753073
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19620,852,1.11 [0.98-1.26],0.1046053914648935
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19740,66,1.15 [0.75-1.78],0.5138770690237668
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17975,882,1.05 [0.93-1.19],0.4370162874348642
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17317,960,1.06 [0.94-1.20],0.3369533431957415
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17153,196,1.03 [0.79-1.36],0.8102589663142414
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13902,1832,0.99 [0.91-1.09],0.8930091059912255
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17088,325,1.15 [0.94-1.39],0.1751635266867638
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19787,1019,1.04 [0.92-1.17],0.5450298342775334
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Mycoses,19870,366,1.02 [0.84-1.25],0.8160080316403924
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19152,709,0.96 [0.82-1.11],0.5601892639801065
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19810,974,1.04 [0.92-1.18],0.5082678479343794
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18920,152,0.80 [0.57-1.14],0.223585783680654
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19905,39,1.14 [0.64-2.02],0.6663489150856273
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19683,847,1.06 [0.93-1.21],0.3551862292498513
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19726,52,0.44 [0.23-0.87],0.0184678403935366
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19845,99,1.16 [0.81-1.67],0.4230481071118526
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19830,84,1.26 [0.87-1.83],0.2118759655999684
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18836,393,1.19 [0.99-1.41],0.0583690298209565
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18673,230,0.90 [0.68-1.18],0.4274072752607313
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18837,69,1.11 [0.71-1.71],0.6529699584386746
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19886,57,1.41 [0.94-2.13],0.1005346184445718
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19857,121,0.95 [0.66-1.37],0.789403890823721
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral warts,19782,46,1.00 [0.56-1.78],0.987511965633531
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19778,42,0.97 [0.52-1.79],0.9138923490183652
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm,19650,290,0.87 [0.68-1.11],0.2626974191476225
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19848,41,0.90 [0.46-1.73],0.7409539586197159
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19814,48,0.80 [0.43-1.50],0.4866968005493133
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19867,104,0.59 [0.37-0.93],0.0244165811606384
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19591,1375,0.96 [0.86-1.06],0.4103956405518801
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of meninges,19904,26,1.18 [0.60-2.31],0.6365080232263488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19850,56,1.33 [0.87-2.03],0.1844567995637773
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19892,63,0.78 [0.45-1.35],0.36880457723096
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19881,383,0.88 [0.72-1.09],0.2547045885274148
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Caecum,19885,288,0.96 [0.76-1.22],0.766149370776329
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19796,63,0.98 [0.60-1.60],0.9254231539650554
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,19880,242,1.08 [0.85-1.38],0.5095283066506269
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Rectum,19842,352,1.06 [0.87-1.30],0.5435261453413558
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19801,622,0.96 [0.82-1.13],0.6089421366888729
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19869,460,0.89 [0.74-1.08],0.2522774017975248
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15523,61,1.22 [0.79-1.89],0.3772980948752276
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15522,60,0.93 [0.56-1.56],0.7908555236814936
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19876,79,1.22 [0.83-1.80],0.3085806940019096
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",19876,76,1.20 [0.81-1.79],0.357819721912801
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Lung cancer and mesothelioma,13272,297,0.90 [0.70-1.17],0.4417528975190495
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Lymphoid leukaemia,15518,56,0.99 [0.59-1.67],0.9778786279970044
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15625,163,0.95 [0.69-1.30],0.7360412877326379
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",15700,238,0.77 [0.58-1.03],0.0764466721635388
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15536,74,1.26 [0.87-1.83],0.2155538866454947
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",15570,108,0.74 [0.49-1.14],0.1747468599329177
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",15585,123,1.12 [0.81-1.56],0.4965241751286787
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15525,63,1.30 [0.86-1.95],0.2089503053283945
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16606,1144,0.94 [0.83-1.06],0.2891687299521974
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",15586,124,1.01 [0.71-1.42],0.9759931954820972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15554,92,0.81 [0.52-1.27],0.3651155776068669
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,15563,101,1.01 [0.69-1.49],0.9500944838816572
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi,19807,141,0.60 [0.40-0.89],0.0115253348613262
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi of trunk,19878,84,0.60 [0.36-1.00],0.0478570318236616
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanoma in situ,15489,61,1.19 [0.77-1.85],0.4347273745816659
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",15546,84,1.12 [0.76-1.65],0.5622425611988512
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15598,136,0.93 [0.66-1.31],0.6779533632982901
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",15653,191,0.84 [0.62-1.13],0.2502541331841557
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",15546,84,0.90 [0.58-1.41],0.6558224538136518
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Other benign neoplasms of skin,19794,122,0.86 [0.59-1.26],0.440946481772468
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16452,990,0.99 [0.87-1.12],0.884464993210789
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16511,1049,1.00 [0.89-1.13],0.96467598788361
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19676,241,1.06 [0.83-1.35],0.642876289761739
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18502,65,0.83 [0.49-1.41],0.4918241578656201
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19490,55,0.85 [0.48-1.50],0.572931775193716
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19465,2236,1.03 [0.95-1.12],0.426558141441104
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18896,52,1.09 [0.66-1.81],0.7306067296752179
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19560,38,1.07 [0.58-1.97],0.8300163180088129
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19617,1180,1.00 [0.89-1.12],0.9919354728324288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19615,1178,1.00 [0.89-1.12],0.994952252503966
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18514,77,0.91 [0.57-1.46],0.7076257746203278
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19717,873,1.04 [0.91-1.18],0.6030729664068561
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19615,93,1.33 [0.95-1.84],0.0922583409227928
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19496,61,1.30 [0.85-2.01],0.22881076003988
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19491,56,0.62 [0.33-1.16],0.1369852154005179
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19764,242,1.18 [0.94-1.48],0.1491654001562299
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19826,39,0.88 [0.45-1.73],0.7195799472110701
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19721,199,1.23 [0.96-1.56],0.0999549567677078
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18904,60,0.97 [0.58-1.61],0.8982309090693138
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,14746,303,0.89 [0.70-1.13],0.3304988251495511
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18193,135,0.94 [0.66-1.33],0.7128831697058101
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18215,157,0.80 [0.57-1.14],0.220194139666875
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14493,50,0.80 [0.43-1.48],0.4820247272238206
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18770,52,0.69 [0.37-1.30],0.2479801811741271
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18152,179,0.99 [0.74-1.33],0.968495654842404
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19522,480,0.92 [0.76-1.11],0.3730911707830736
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19241,199,1.08 [0.83-1.40],0.5503860241863243
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19158,116,1.00 [0.69-1.43],0.989801298419276
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19656,938,0.88 [0.77-1.01],0.0783505584788686
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17074,906,0.90 [0.79-1.04],0.1500290103139873
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14504,61,0.81 [0.46-1.42],0.4586229900209343
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19208,36,1.00 [0.52-1.92],0.9970849029166556
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,14657,214,1.15 [0.90-1.47],0.2591381483689683
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14503,60,0.92 [0.54-1.57],0.7726143104724977
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17646,3203,1.01 [0.94-1.09],0.7213881898379897
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14591,148,1.17 [0.87-1.57],0.2988892444878528
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,14895,452,1.09 [0.92-1.30],0.3305116234917354
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19858,220,1.30 [1.04-1.62],0.0193547900082364
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19706,68,1.45 [1.01-2.07],0.0434074635015015
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14569,126,1.02 [0.72-1.45],0.8996373611652135
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14494,51,1.62 [1.15-2.30],0.0061892532166821
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19755,583,1.00 [0.85-1.18],0.991228964798253
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14685,242,1.02 [0.79-1.30],0.9010887294107136
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,14720,277,1.09 [0.87-1.37],0.4438938998211439
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15039,596,1.07 [0.92-1.25],0.3951301210684274
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14554,111,1.03 [0.72-1.49],0.8663844496368386
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19700,62,1.53 [1.08-2.18],0.0171926187227017
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14913,470,0.95 [0.79-1.15],0.6129379462186249
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,14774,331,1.16 [0.95-1.41],0.1395367930471498
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18020,47,1.03 [0.58-1.81],0.9261854925733476
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18742,4299,0.99 [0.93-1.05],0.7766889596905018
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19183,11,0.65 [0.16-2.61],0.5472422998808049
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19193,21,0.40 [0.14-1.19],0.0992428520184168
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19767,1468,0.99 [0.90-1.10],0.9044060827632168
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19765,1465,1.00 [0.90-1.11],0.9396601702602267
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19184,12,1.81 [0.87-3.76],0.1135460292449524
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19683,679,1.15 [1.00-1.32],0.0471330386715618
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15753,1310,1.00 [0.90-1.11],0.9925514049781292
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19896,194,1.20 [0.93-1.54],0.1639823371120277
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19125,83,1.13 [0.75-1.69],0.5655677525734066
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19066,62,0.53 [0.29-0.96],0.0363558836260628
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19073,69,1.34 [0.92-1.96],0.1290724219755807
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14497,54,1.30 [0.83-2.04],0.2487782169698898
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17576,139,1.08 [0.79-1.47],0.6422079239037384
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2108,103,1.63 [1.19-2.21],0.0020059424972402
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2244,266,0.74 [0.57-0.98],0.0333842796025736
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17515,78,0.84 [0.52-1.35],0.4693374410251626
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2061,56,1.56 [0.99-2.45],0.0559020634809549
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19272,1835,0.91 [0.82-1.00],0.0446407044307082
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19313,271,1.10 [0.88-1.36],0.4175057010664146
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18169,196,0.97 [0.73-1.30],0.8504603602669997
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15065,622,0.99 [0.84-1.16],0.8780827128577556
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19800,206,0.94 [0.71-1.24],0.6479333490545502
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18902,228,1.21 [0.97-1.52],0.094649794308117
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Angina pectoris,17500,1232,0.97 [0.86-1.08],0.5540803173615287
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18996,322,1.16 [0.95-1.41],0.1394688845649906
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18742,68,1.11 [0.71-1.76],0.6408562089694292
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18863,189,1.21 [0.94-1.55],0.1397188839061501
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11641,1890,0.98 [0.90-1.08],0.7007419789718676
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,AV-block,16075,496,1.05 [0.89-1.25],0.5475023673688206
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19846,421,1.12 [0.94-1.34],0.2202323988003596
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,9961,210,1.27 [1.00-1.60],0.0478276384168639
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15747,168,0.93 [0.67-1.28],0.6448339389455447
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",15667,88,0.91 [0.58-1.41],0.6708508241144426
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19906,50,1.10 [0.65-1.85],0.7334212529203369
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Conduction disorders,16679,1100,0.99 [0.88-1.12],0.9334555919800936
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18441,2194,1.03 [0.95-1.12],0.5255012112815423
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16836,6522,1.02 [0.97-1.07],0.4219438540778768
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18882,225,0.97 [0.75-1.27],0.8417693322827386
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Endocarditis,15649,70,1.26 [0.83-1.89],0.2754070304575519
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19640,1086,1.02 [0.91-1.15],0.6958673571507309
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertension,17826,5669,1.01 [0.96-1.06],0.713422919129995
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17831,5674,1.01 [0.96-1.06],0.7292676487990741
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19712,93,1.24 [0.88-1.75],0.2170577297859151
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12321,164,1.05 [0.79-1.39],0.7522249744252865
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12256,99,1.33 [0.98-1.80],0.0691567282272375
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypotension,19785,980,0.95 [0.83-1.08],0.3959536634487358
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19029,95,0.87 [0.56-1.33],0.5151190852355847
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18552,2284,1.00 [0.92-1.09],0.9889808048135426
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19565,545,0.88 [0.73-1.05],0.1466950106090114
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15912,333,0.98 [0.78-1.22],0.8313164000812315
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19313,881,1.07 [0.94-1.21],0.3151383721349203
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17032,764,1.07 [0.94-1.23],0.3042102877449835
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19767,188,1.00 [0.75-1.34],0.9985879273985472
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19862,309,1.07 [0.87-1.33],0.5215794632515196
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,18712,55,1.35 [0.90-2.04],0.148193063133566
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other aneurysm,18752,78,1.24 [0.84-1.83],0.2882290689622761
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,15976,397,0.99 [0.81-1.21],0.9037553361231614
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18784,110,1.02 [0.70-1.49],0.9113865960309891
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18900,226,1.11 [0.86-1.42],0.4205482922199817
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15731,152,0.94 [0.68-1.31],0.7289968468336985
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,18729,72,0.69 [0.40-1.17],0.1689778851026946
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18699,42,1.60 [1.05-2.44],0.0286630119515489
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18605,72,1.10 [0.71-1.69],0.6704678248113729
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18741,84,0.96 [0.62-1.49],0.8564925612745707
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16604,1025,0.99 [0.87-1.12],0.8695414386832734
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18858,53,1.29 [0.82-2.05],0.2738462192047029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19135,461,1.12 [0.94-1.33],0.1911210432041278
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19378,305,0.97 [0.77-1.21],0.7900269177156857
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19076,543,1.04 [0.88-1.23],0.6345807388287094
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10059,308,1.21 [0.99-1.48],0.0692020043616401
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19055,422,1.16 [0.97-1.38],0.1020396824856337
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18946,289,0.92 [0.73-1.17],0.5177429671391784
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19473,400,0.99 [0.81-1.21],0.9454639800182886
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19853,576,0.92 [0.78-1.09],0.3389431708281268
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,15966,387,0.90 [0.72-1.11],0.3124004449459612
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19377,304,0.96 [0.77-1.21],0.7495308599524331
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18717,184,0.99 [0.74-1.32],0.9274908078806438
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19551,617,0.87 [0.74-1.03],0.1147374303658735
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19540,640,0.85 [0.72-1.01],0.0647847824508596
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19013,35,0.45 [0.20-1.03],0.0591883112775276
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18768,95,1.05 [0.71-1.56],0.7991581897469526
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19213,193,0.81 [0.59-1.10],0.1745381903183323
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18689,257,1.14 [0.91-1.43],0.2471941101640411
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,18971,314,0.91 [0.73-1.15],0.4471792216703513
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18689,61,0.61 [0.34-1.12],0.1111126518162621
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19700,629,0.96 [0.82-1.13],0.6035287693089351
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19731,408,0.85 [0.69-1.05],0.1247861877989099
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17146,814,1.14 [1.00-1.29],0.0456019414437885
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Any mental disorder,19320,2988,1.01 [0.94-1.09],0.7577322685793151
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19676,477,0.87 [0.72-1.06],0.1589982191554436
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17304,972,0.89 [0.78-1.02],0.0988493294489036
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16393,61,1.33 [0.87-2.03],0.1954346899645665
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Smoking dependency,19339,1284,0.99 [0.88-1.11],0.8208439257500342
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17877,1545,0.99 [0.89-1.10],0.795255967160399
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Vascular dementia,19519,120,0.87 [0.60-1.27],0.4727615698149362
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Alzheimer disease,19905,247,1.05 [0.82-1.33],0.7113807657818576
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13328,48,1.32 [0.84-2.07],0.2325642566168244
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Bell's palsy,18766,67,1.50 [1.05-2.13],0.0260710836100363
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18989,290,1.00 [0.79-1.26],0.9967491503127706
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral cysts,19576,196,1.12 [0.87-1.46],0.3754372632954565
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19830,284,1.03 [0.82-1.29],0.8016256894443635
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19501,55,0.94 [0.54-1.63],0.8279122157638032
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19891,62,1.15 [0.73-1.81],0.5580839412073143
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19457,77,0.94 [0.59-1.49],0.7882718465120017
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Epilepsy,18574,225,0.92 [0.70-1.21],0.5511107142372735
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19459,1110,0.97 [0.86-1.09],0.5904149316239887
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19874,392,0.92 [0.75-1.13],0.447892606339041
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19442,1764,0.92 [0.84-1.02],0.103971839541635
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,19594,51,0.84 [0.46-1.53],0.5613692221575963
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hemiplegia,19768,222,1.13 [0.89-1.44],0.3254480521905965
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hydrocephalus,19427,47,1.07 [0.61-1.86],0.8211908316983697
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19889,49,1.08 [0.63-1.84],0.78398052413202
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18719,20,1.42 [0.73-2.76],0.3084905280006685
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18778,79,1.53 [1.10-2.12],0.0110781428957895
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Memory loss,19384,101,0.79 [0.51-1.21],0.2775569507437234
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Migraine,18511,162,0.94 [0.68-1.29],0.7005235076586653
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19886,147,0.94 [0.67-1.31],0.7055627452339767
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Motor neuron disease,13429,137,1.06 [0.77-1.47],0.7179678776070986
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19805,57,1.00 [0.59-1.69],0.9943932008915568
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19503,804,1.04 [0.91-1.19],0.5531745641797494
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Neurological diseases,18790,2924,0.98 [0.91-1.05],0.5264336267714238
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19627,181,1.08 [0.81-1.42],0.6056466380079488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19006,307,1.03 [0.83-1.29],0.782307561484983
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19828,289,1.08 [0.87-1.34],0.4896918810529521
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15724,508,1.04 [0.88-1.23],0.6405213838674095
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19439,59,0.54 [0.29-1.00],0.0490927421143868
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19505,125,0.93 [0.65-1.34],0.7003714770062976
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19591,109,1.11 [0.78-1.57],0.5677319790157307
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18782,83,1.40 [0.99-1.98],0.0545092109213328
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other headache syndromes,18383,34,0.78 [0.37-1.63],0.5050966687231717
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other neurological diseases,19806,426,0.98 [0.81-1.19],0.8573555657588038
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other sleep disorders,18920,571,1.01 [0.86-1.20],0.8760876889914587
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Parkinson's disease,19885,264,0.78 [0.59-1.02],0.0681499196806167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19402,22,1.19 [0.56-2.51],0.6489889366064217
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,19904,36,0.95 [0.49-1.85],0.8746605222714254
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Sleep apnoea,19657,516,1.03 [0.87-1.23],0.705361022302765
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19586,47,1.25 [0.77-2.01],0.3661309691450829
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19888,158,1.10 [0.82-1.48],0.5237211348353119
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18728,29,1.43 [0.84-2.46],0.191688460193846
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19905,250,1.11 [0.88-1.39],0.3773269837299801
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19492,116,0.87 [0.60-1.27],0.474695491528853
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19457,68,1.09 [0.70-1.71],0.6915675491687063
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19624,242,0.86 [0.66-1.13],0.2804585729654946
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19756,248,0.73 [0.55-0.97],0.0293172192374637
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19179,40,1.32 [0.81-2.13],0.2622655651496854
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19192,53,1.11 [0.67-1.85],0.6779738936485167
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19831,35,0.77 [0.37-1.62],0.490942382643764
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19717,101,1.08 [0.74-1.57],0.6853232802982441
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2061,56,1.56 [0.99-2.44],0.0535268497990712
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2514,108,1.67 [1.24-2.25],0.0007099925350142
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19469,80,0.80 [0.49-1.30],0.3685211484523671
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19715,829,0.91 [0.79-1.05],0.2081671851630071
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19644,505,1.06 [0.90-1.26],0.4774619618438662
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19253,114,1.36 [1.03-1.81],0.0320983890854994
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19847,465,0.88 [0.73-1.07],0.2084046892975656
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19903,56,0.86 [0.49-1.51],0.5959255409927423
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19794,412,0.89 [0.73-1.09],0.2675382724748181
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19872,256,1.11 [0.89-1.40],0.3588450482311579
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19830,123,0.80 [0.54-1.19],0.2706788359015618
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19202,63,1.27 [0.85-1.89],0.2441141962350965
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19210,71,1.05 [0.67-1.63],0.8427861930613543
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19174,35,1.27 [0.75-2.15],0.3643305464503282
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19828,577,0.98 [0.83-1.15],0.7642935293805229
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19415,164,0.97 [0.71-1.32],0.8566720697698547
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19403,21,0.96 [0.40-2.29],0.9186878967731684
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19696,80,1.05 [0.69-1.60],0.8251962599161532
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19796,180,1.19 [0.91-1.54],0.1981990915215991
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19526,144,1.04 [0.75-1.43],0.8134740194749335
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19771,64,0.81 [0.47-1.39],0.4412347898854314
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19630,379,0.90 [0.73-1.11],0.3337466917261208
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19488,99,1.13 [0.79-1.63],0.4964023747689389
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18797,1472,1.01 [0.92-1.12],0.7882113515468469
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19772,156,1.24 [0.95-1.63],0.1196559610529891
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19890,119,1.25 [0.92-1.69],0.1599000530680397
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19488,349,1.18 [0.98-1.42],0.0848723017804012
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19673,57,1.37 [0.92-2.03],0.1237583393449784
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19893,46,0.77 [0.40-1.47],0.4222156041354703
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19199,60,0.89 [0.52-1.51],0.6582678955840071
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19262,123,0.86 [0.59-1.26],0.442834584125963
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18987,101,0.82 [0.54-1.25],0.3597093963513075
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19420,38,0.88 [0.44-1.75],0.7160473127478232
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18941,55,1.27 [0.82-1.96],0.2883364830082106
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19295,44,0.61 [0.30-1.24],0.1697097777791214
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19420,169,0.89 [0.64-1.22],0.4536973134875067
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19231,92,1.22 [0.86-1.72],0.2730293596074223
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18988,102,1.09 [0.75-1.58],0.6617806306155072
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18960,74,1.17 [0.78-1.77],0.4443118570437407
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,18510,1185,0.92 [0.82-1.03],0.1640823045672143
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19186,47,1.40 [0.93-2.11],0.1022108855082734
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19701,312,0.96 [0.77-1.21],0.7444665499385281
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19446,57,0.88 [0.51-1.54],0.6652309725391161
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19511,122,0.94 [0.65-1.35],0.7264137029436535
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19750,50,1.16 [0.70-1.93],0.552652597594117
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19871,105,1.34 [0.98-1.82],0.063304963946321
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19792,97,0.87 [0.57-1.33],0.5234096122179989
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19745,45,0.88 [0.47-1.63],0.6803732686460013
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19744,44,1.34 [0.83-2.17],0.2236835340930306
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19820,778,1.10 [0.96-1.25],0.1684067069727495
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19619,577,1.08 [0.93-1.26],0.3277104013708055
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19151,109,1.05 [0.74-1.51],0.771402416066428
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19110,68,1.29 [0.87-1.92],0.2053959252613779
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,19724,46,0.68 [0.35-1.34],0.2658771691690219
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19834,156,0.61 [0.42-0.89],0.009236040200194
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19728,50,0.52 [0.27-1.02],0.0556510127379975
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,All influenza,18055,81,0.74 [0.45-1.22],0.2353442693507957
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18053,79,0.71 [0.43-1.18],0.1893639889696762
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13061,86,1.34 [0.94-1.90],0.1034039781787713
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,19822,235,1.23 [0.98-1.54],0.076961434217547
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13883,1195,1.04 [0.93-1.17],0.4867154586717185
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14149,1174,1.02 [0.91-1.15],0.717365340957665
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19582,116,1.06 [0.75-1.51],0.7234541481917782
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18046,72,1.08 [0.71-1.67],0.7115257179283324
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Bronchiectasis,17295,237,0.92 [0.71-1.19],0.530467309792527
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17093,35,1.05 [0.55-2.02],0.8817457483966439
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19188,2130,1.01 [0.93-1.10],0.7718151102685795
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18669,69,0.85 [0.51-1.42],0.5338760527295927
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,18732,132,0.92 [0.64-1.31],0.6308792014730783
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19719,1088,0.92 [0.81-1.04],0.1705087774721193
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,18723,123,0.81 [0.55-1.20],0.3027274830797004
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18206,4358,1.01 [0.96-1.08],0.6572545443352247
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18939,339,0.88 [0.70-1.10],0.2674300368027853
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Early onset COPD,18904,273,1.07 [0.84-1.35],0.5909280115867486
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Emphysema,17355,297,1.08 [0.87-1.34],0.4732150050792366
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19112,295,0.74 [0.58-0.96],0.0224065621626246
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19693,1719,0.88 [0.80-0.97],0.012807688280499
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,19133,316,0.74 [0.58-0.94],0.0159599023791861
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Later onset COPD,18972,815,0.86 [0.75-1.00],0.0459421665169379
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19890,327,1.08 [0.88-1.33],0.4386575767112031
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Nasal polyp,18726,126,1.03 [0.73-1.46],0.8462980201056347
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19672,802,0.98 [0.85-1.13],0.7712598631677423
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,19665,1821,0.99 [0.91-1.09],0.8848230449758389
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19352,752,1.00 [0.86-1.15],0.9615405950182648
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other pleural conditions,17895,51,1.02 [0.59-1.76],0.9421995324814976
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19814,384,0.80 [0.64-0.99],0.0432566902598144
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19800,1157,0.92 [0.81-1.03],0.1592571235168878
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,18761,917,1.01 [0.89-1.15],0.8589848156586397
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural plaque,18066,222,0.93 [0.71-1.22],0.6081319193492016
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19481,1507,0.90 [0.81-1.00],0.053188452205076
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19803,240,1.22 [0.98-1.53],0.0706130603887701
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pneumothorax,17960,116,0.90 [0.61-1.33],0.6114537089224482
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pollen allergy,19892,203,1.22 [0.95-1.55],0.1140252691205774
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,19486,56,1.00 [0.60-1.69],0.9886623910209672
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13025,50,1.07 [0.64-1.82],0.7881245609152814
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19657,787,0.99 [0.86-1.14],0.885868387595609
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18836,236,1.22 [0.97-1.53],0.0889507233519715
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Viral pneumonia,18199,225,0.73 [0.54-0.98],0.0381399114210532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19603,191,0.75 [0.55-1.04],0.0822119679712717
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8720,97,0.95 [0.62-1.43],0.7903231105791967
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,13925,73,0.89 [0.54-1.45],0.6311566213055149
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute appendicitis,19795,119,1.13 [0.81-1.57],0.4806091777416621
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute gastritis,15084,70,1.37 [0.95-1.97],0.0899962023869319
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,18785,172,1.06 [0.80-1.42],0.6773544315794983
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute peritonitis,19602,79,1.04 [0.68-1.60],0.8509504591787845
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19160,92,1.38 [0.99-1.93],0.0557020302564894
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,15439,425,1.15 [0.97-1.37],0.1112512562017887
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18711,98,1.33 [0.96-1.85],0.0868944251464902
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19570,98,1.32 [0.95-1.84],0.093303796139439
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholecystitis,18793,180,1.10 [0.83-1.45],0.5087843898182175
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholelithiasis,19274,661,0.97 [0.83-1.13],0.6835527720335062
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic gastritis,15229,215,1.28 [1.02-1.61],0.0340637346575029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18659,46,1.34 [0.83-2.17],0.2371978222700164
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19736,117,1.04 [0.73-1.48],0.8472062301878522
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Coeliac disease,18525,73,1.13 [0.74-1.73],0.5747483774108004
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Collagenous colitis,18698,41,1.04 [0.57-1.91],0.8940270522847383
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19757,185,1.09 [0.82-1.43],0.5645284708297631
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Constipation,19768,1287,1.04 [0.93-1.15],0.5185767146658804
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn disease,18731,74,1.02 [0.65-1.60],0.9324652975104172
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19619,53,1.08 [0.65-1.80],0.7569419412096102
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18719,62,0.99 [0.60-1.63],0.9555216178296136
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Dental caries,19376,188,1.17 [0.90-1.52],0.2497418600813321
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16886,1606,1.04 [0.94-1.14],0.4510914142558152
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of appendix,19821,145,1.12 [0.83-1.52],0.4654066685974299
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of liver,19790,722,0.99 [0.85-1.15],0.8802132131079756
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18227,3213,1.04 [0.98-1.12],0.2157573939121783
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19602,414,1.07 [0.89-1.29],0.4686881790134918
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19865,342,0.95 [0.77-1.19],0.6775276916688692
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19276,88,1.01 [0.66-1.53],0.9776656862998168
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19166,50,0.94 [0.53-1.68],0.8463988142312535
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19636,1184,1.10 [0.99-1.23],0.069833618322962
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of tongue,19178,96,0.89 [0.58-1.36],0.5915757777762252
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19609,996,1.02 [0.90-1.16],0.7260149659420243
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16414,2562,1.10 [1.02-1.18],0.0113981326055246
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,15227,213,0.98 [0.75-1.29],0.8903734610928828
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19804,165,1.06 [0.79-1.43],0.6882618994792775
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19846,33,1.20 [0.65-2.23],0.5554276233836463
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19204,136,0.96 [0.69-1.35],0.8342771281087984
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14001,149,1.20 [0.89-1.61],0.2247931080796274
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,15363,349,0.83 [0.66-1.04],0.1093037935164511
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastric ulcer,15320,306,1.12 [0.90-1.38],0.309235902858681
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16793,1779,1.00 [0.91-1.09],0.9317334281344192
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15501,487,1.04 [0.87-1.23],0.6908708806305206
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15231,6644,1.02 [0.97-1.07],0.4308164895999961
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,GI-bleeding,19435,983,1.09 [0.96-1.22],0.1751979510810706
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19232,44,1.28 [0.76-2.13],0.349826598636113
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,14642,1017,1.04 [0.91-1.17],0.5837668833696712
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19139,71,1.49 [1.06-2.10],0.0227413850147212
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Hernia,18194,2914,0.95 [0.88-1.03],0.1915996061761447
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impacted teeth,19849,32,1.26 [0.69-2.31],0.4544811199643928
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impaction of intestines,13888,36,0.57 [0.26-1.27],0.1717451871291636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Inguinal hernia,16634,1354,0.89 [0.80-1.00],0.0471477545560225
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15443,163,0.80 [0.57-1.12],0.1997471422953279
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,13927,75,1.09 [0.70-1.69],0.7117737521615031
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18538,86,1.14 [0.77-1.69],0.5142746907399849
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14091,239,1.05 [0.82-1.36],0.6805273762565762
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19870,309,0.88 [0.70-1.12],0.3020239118774512
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19220,563,1.16 [1.00-1.35],0.0546279716787663
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19395,738,1.12 [0.98-1.28],0.0884828177380445
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15191,177,1.30 [1.02-1.66],0.0374098968075468
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophagitis,15534,520,1.09 [0.92-1.28],0.3053818088075123
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19856,87,0.93 [0.60-1.44],0.7436606785009026
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15342,62,0.48 [0.26-0.89],0.019993541833969
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15065,1213,1.15 [1.04-1.28],0.0073625967973666
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18824,211,1.19 [0.93-1.51],0.1667632884356973
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18710,97,1.11 [0.76-1.62],0.59126200180593
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,15442,1590,1.03 [0.93-1.14],0.538446337793013
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,18390,4538,1.07 [1.01-1.13],0.0190543597789179
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19144,144,0.92 [0.66-1.30],0.643478403702146
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of liver,19639,571,0.97 [0.82-1.14],0.6808924857512433
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15610,596,1.12 [0.97-1.30],0.1349746358255469
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18724,111,1.28 [0.94-1.76],0.1185955446393598
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19810,287,0.90 [0.70-1.15],0.3876650018212925
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15668,654,1.15 [1.00-1.32],0.052748865253517
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19444,992,1.10 [0.98-1.24],0.0945402086769142
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19328,140,1.26 [0.95-1.68],0.11098869046162
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15170,1318,1.05 [0.94-1.17],0.3628779116200318
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16554,1540,1.06 [0.96-1.17],0.2281597059728337
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19144,76,0.76 [0.46-1.26],0.2865999069446536
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19304,647,1.16 [1.01-1.34],0.0357933035763025
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14135,283,1.01 [0.80-1.28],0.9353395749034812
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19837,38,1.17 [0.65-2.10],0.6024097746303033
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14239,387,1.03 [0.85-1.26],0.7631362359080995
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18590,138,0.97 [0.69-1.36],0.8426941629177531
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19891,34,0.60 [0.27-1.35],0.2179943477521254
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19194,83,0.93 [0.59-1.46],0.7607699204985603
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Toxic colitis,18694,37,1.03 [0.55-1.93],0.9245425076260844
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15261,247,1.19 [0.95-1.49],0.1305900845469645
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,18779,122,0.89 [0.61-1.29],0.5383344847907391
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18759,102,0.92 [0.62-1.38],0.6938088057175301
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Umbilical hernia,15582,302,0.90 [0.71-1.14],0.3809149411500329
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,13982,130,1.01 [0.71-1.43],0.961727831417812
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,15495,215,0.93 [0.70-1.22],0.5935600100793299
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Volvulus,13911,59,0.61 [0.33-1.12],0.1121410229320516
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19851,263,1.11 [0.89-1.39],0.3528143144849599
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19646,60,1.12 [0.70-1.78],0.6446604656158137
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18278,80,1.12 [0.75-1.67],0.5886128633363199
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19278,626,0.86 [0.73-1.02],0.0837615299485078
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18825,173,0.92 [0.67-1.26],0.6107801641772721
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18567,369,0.90 [0.72-1.11],0.3236872001221691
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19660,221,0.95 [0.73-1.25],0.7179148463474898
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19824,385,0.96 [0.78-1.18],0.6885001992260802
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19476,37,1.15 [0.65-2.05],0.624735996123174
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18643,2598,1.00 [0.92-1.08],0.9300273610779132
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19521,331,0.95 [0.76-1.19],0.678272372504773
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19428,238,0.96 [0.74-1.25],0.7772248502326183
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19509,857,0.89 [0.77-1.03],0.1082315428770089
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19896,25,0.86 [0.37-1.99],0.7198752445385264
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18221,23,1.25 [0.63-2.50],0.5284442698661147
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19236,46,1.18 [0.71-1.95],0.5188597578055636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19656,217,0.95 [0.72-1.24],0.697794800403776
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18596,398,1.01 [0.83-1.23],0.9153525637843102
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18260,62,0.83 [0.48-1.45],0.5164262097638972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19849,65,0.79 [0.46-1.36],0.39856923474871
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18822,170,1.04 [0.77-1.39],0.8102785005610961
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19761,175,0.80 [0.58-1.11],0.1822208521306977
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19493,54,0.70 [0.37-1.30],0.2577302148742925
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18246,48,0.90 [0.50-1.64],0.7329109853317854
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19514,1316,0.99 [0.89-1.11],0.8960997220292848
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18633,435,0.97 [0.80-1.18],0.7748033582329478
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18263,65,0.78 [0.45-1.36],0.3800156657776921
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19830,244,0.93 [0.71-1.20],0.5597878928014024
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19485,46,1.16 [0.68-1.99],0.5847697384314376
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19799,213,0.88 [0.66-1.16],0.3619499980754402
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19867,279,1.13 [0.91-1.40],0.2597450550724185
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18274,76,0.93 [0.59-1.49],0.7726167118935682
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18416,218,1.00 [0.77-1.31],0.985340892240228
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19861,273,1.13 [0.91-1.40],0.2644825531336593
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18405,207,1.07 [0.82-1.39],0.6266313748231709
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19883,99,1.05 [0.71-1.54],0.8141947416837665
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17186,66,0.79 [0.46-1.36],0.3955703885660085
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18150,3972,0.99 [0.93-1.06],0.7986706440203415
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16977,2799,1.00 [0.93-1.08],0.9712012674302022
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17182,62,1.14 [0.71-1.83],0.580230124038044
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17527,122,0.90 [0.62-1.31],0.5885851593792676
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17519,114,1.09 [0.76-1.55],0.6400530970431106
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19727,54,1.04 [0.61-1.77],0.8920762741698951
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17468,63,1.24 [0.81-1.89],0.3260977837873183
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14899,721,0.91 [0.78-1.06],0.2144097690776193
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19801,126,1.05 [0.75-1.47],0.7800429323847136
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17618,213,0.85 [0.64-1.14],0.2807907272736181
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16942,5190,1.00 [0.95-1.06],0.9514548848459334
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19045,78,0.88 [0.55-1.41],0.5989761607619933
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17253,133,1.18 [0.86-1.61],0.3034717214150629
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17492,372,1.21 [1.01-1.45],0.0372474077308436
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19220,1815,1.00 [0.91-1.10],0.9674819043016524
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17432,312,1.19 [0.98-1.45],0.0798959988973781
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17167,47,0.90 [0.49-1.66],0.7388577258474945
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17204,84,0.74 [0.46-1.21],0.235775867010695
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19640,26,0.58 [0.23-1.47],0.2487745035352378
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15378,1200,0.96 [0.86-1.08],0.5425171848014194
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14968,790,0.97 [0.84-1.12],0.6851738189409577
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19786,777,1.00 [0.87-1.15],0.9667292809403716
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14215,37,1.11 [0.62-2.01],0.7241375748031671
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14245,67,0.86 [0.51-1.45],0.5755358420318876
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17336,216,1.16 [0.90-1.48],0.2465061600981409
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14706,528,1.09 [0.93-1.29],0.293489965775397
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17437,32,0.41 [0.17-0.97],0.0433306295166948
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17836,431,0.88 [0.72-1.08],0.2100214330611127
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17620,215,1.08 [0.84-1.39],0.560169152870216
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14669,491,1.08 [0.91-1.29],0.3540895729879311
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17174,54,0.84 [0.47-1.50],0.5637568866416514
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17159,39,1.53 [0.96-2.44],0.0715777587712036
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19038,71,1.01 [0.64-1.59],0.9705209183750996
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19664,697,0.90 [0.77-1.06],0.2000398118898073
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19287,320,0.87 [0.69-1.10],0.2579328787101088
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19840,250,1.16 [0.92-1.45],0.204638019535842
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,15734,1556,1.03 [0.93-1.13],0.6027373824236776
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14223,45,0.77 [0.40-1.49],0.4316696747467861
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17184,64,1.35 [0.90-2.03],0.1432816698180029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14227,49,0.63 [0.33-1.24],0.1822358006706998
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14214,36,0.73 [0.34-1.54],0.4036359831296816
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19123,156,1.00 [0.73-1.37],0.9883074620698272
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19098,131,0.94 [0.66-1.33],0.7126479721070635
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19877,68,0.94 [0.57-1.54],0.8082016896891906
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18645,1240,0.98 [0.88-1.10],0.7897779991774234
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17175,55,1.03 [0.61-1.76],0.9023875679210634
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14211,33,1.45 [0.86-2.43],0.1624533732700828
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17912,507,0.94 [0.78-1.12],0.4959526409943895
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15601,1423,1.03 [0.93-1.14],0.6283162892434635
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19657,43,0.96 [0.52-1.76],0.8845021727935289
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19891,54,1.16 [0.71-1.88],0.5492310874675251
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17190,70,0.77 [0.45-1.31],0.3310302278897617
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17917,797,1.07 [0.93-1.22],0.3521579850696438
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17195,75,1.00 [0.63-1.58],0.9962103532144588
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15187,1009,0.95 [0.83-1.07],0.39597033863105
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19039,72,0.95 [0.59-1.53],0.8315474148875214
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17157,37,1.22 [0.69-2.16],0.50280670452966
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,17500,95,0.85 [0.56-1.31],0.473497778620613
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17524,404,1.07 [0.88-1.29],0.5121493193974156
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19770,156,1.05 [0.77-1.42],0.7585262574547152
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17792,387,1.10 [0.91-1.33],0.3419478286521478
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19849,248,1.15 [0.92-1.45],0.2297819046490635
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19894,32,0.92 [0.45-1.88],0.8084287631128722
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17246,126,1.43 [1.09-1.88],0.0108201616856852
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16353,470,0.92 [0.76-1.11],0.3921875577655942
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17506,386,1.08 [0.89-1.31],0.4594654329987052
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17403,283,1.22 [1.00-1.50],0.0485057379628166
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14202,24,0.89 [0.38-2.07],0.7887064489812592
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16060,1882,0.99 [0.90-1.08],0.8249923101371157
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14543,365,0.89 [0.72-1.11],0.2897278288938144
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19743,129,1.11 [0.80-1.54],0.5260420420441372
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19843,34,1.39 [0.83-2.34],0.2136869867009872
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18262,37,0.84 [0.42-1.70],0.6368540324401246
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14234,56,1.10 [0.67-1.82],0.6985772922139826
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,17478,73,0.99 [0.62-1.56],0.9490216734503591
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14435,257,1.17 [0.94-1.46],0.1640992532479013
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17359,239,1.17 [0.93-1.48],0.1852891881956008
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17589,184,1.19 [0.92-1.53],0.1808524745727169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17470,65,0.68 [0.38-1.19],0.174283999773119
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15830,26,1.06 [0.52-2.16],0.8821548347795759
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19895,33,1.11 [0.59-2.09],0.7421985237646741
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17554,434,1.07 [0.89-1.28],0.4960644142384256
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19630,16,0.83 [0.29-2.37],0.73262920911108
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19000,1880,1.06 [0.97-1.16],0.1639987728618064
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17207,87,0.61 [0.37-1.00],0.0520348338478923
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17809,404,1.03 [0.85-1.25],0.7528385027083712
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19016,169,0.88 [0.64-1.21],0.4463440259032954
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,17519,114,1.16 [0.83-1.62],0.3916497049407343
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18476,1071,1.02 [0.91-1.15],0.6814118161542737
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18062,657,1.01 [0.86-1.17],0.9382451936301752
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17151,31,1.53 [0.91-2.58],0.1076926277498456
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19650,36,1.50 [0.94-2.38],0.0901685327872248
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17227,107,1.42 [1.06-1.91],0.0190083289687219
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17138,18,0.82 [0.29-2.28],0.7011005955523315
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14228,50,0.63 [0.33-1.22],0.172466870228886
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19168,1483,1.08 [0.98-1.19],0.1186579896054049
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19514,334,1.00 [0.81-1.25],0.966315613658278
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19302,122,1.18 [0.86-1.62],0.3018517846880707
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18809,1124,1.14 [1.03-1.27],0.0154627830249913
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19707,49,1.55 [1.07-2.25],0.0218918846649181
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19705,292,1.06 [0.85-1.33],0.5786029041540026
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cystitis,17554,172,1.07 [0.80-1.42],0.6518013218618597
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Dialysis,17751,66,1.61 [1.17-2.22],0.003750158713966
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18860,2758,1.07 [0.99-1.15],0.0719552449939563
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18002,4608,1.05 [0.99-1.11],0.1145907584811436
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19728,70,1.24 [0.82-1.85],0.3056581403046483
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,16273,171,1.02 [0.75-1.38],0.9005627549685501
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17756,289,1.06 [0.85-1.33],0.5846261442087057
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18267,2165,1.06 [0.98-1.15],0.1591147640014229
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16297,195,0.99 [0.74-1.32],0.9441049676156849
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17443,61,0.84 [0.49-1.46],0.5416268314268302
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16200,98,1.27 [0.90-1.80],0.1707635273104666
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19898,52,0.83 [0.46-1.51],0.5483640868501992
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19897,42,1.35 [0.83-2.20],0.2271180417848544
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19224,1842,0.99 [0.91-1.09],0.8961584069387539
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18188,806,1.04 [0.91-1.19],0.5267387726019985
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19848,435,1.06 [0.88-1.27],0.5621423148031631
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16357,255,1.21 [0.97-1.51],0.0892933847916698
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16339,237,1.01 [0.79-1.31],0.9114916707381192
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16290,188,1.02 [0.76-1.35],0.9125955309568043
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19895,41,0.88 [0.46-1.68],0.6914969878375999
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18614,1232,0.97 [0.87-1.09],0.6424893615325786
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17791,324,1.09 [0.89-1.34],0.4099616289320708
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19553,140,1.04 [0.75-1.43],0.8177492746098085
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19711,53,0.94 [0.55-1.64],0.8391288341767534
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16320,218,0.89 [0.67-1.18],0.4292873952924222
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19693,2226,1.10 [1.01-1.19],0.0197774703386294
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17520,53,1.36 [0.88-2.12],0.1687207921102363
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17798,113,0.98 [0.67-1.42],0.8966962929818383
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19244,64,1.18 [0.75-1.85],0.4825591339149176
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17633,251,0.97 [0.75-1.25],0.8135578046421782
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19618,438,1.05 [0.87-1.26],0.6178212801728216
